RU2128170C1 - Производные индолин-2-она и промежуточные продукты для их получения - Google Patents

Производные индолин-2-она и промежуточные продукты для их получения Download PDF

Info

Publication number
RU2128170C1
RU2128170C1 RU95120168A RU95120168A RU2128170C1 RU 2128170 C1 RU2128170 C1 RU 2128170C1 RU 95120168 A RU95120168 A RU 95120168A RU 95120168 A RU95120168 A RU 95120168A RU 2128170 C1 RU2128170 C1 RU 2128170C1
Authority
RU
Russia
Prior art keywords
group
substituted
indolin
methylphenyl
unsubstituted
Prior art date
Application number
RU95120168A
Other languages
English (en)
Russian (ru)
Other versions
RU95120168A (ru
Inventor
Есаки Тору
Емура Такаси
Хосино Ейити
Original Assignee
Чугаи Сейяку Кабусики Кайся
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чугаи Сейяку Кабусики Кайся filed Critical Чугаи Сейяку Кабусики Кайся
Publication of RU95120168A publication Critical patent/RU95120168A/ru
Application granted granted Critical
Publication of RU2128170C1 publication Critical patent/RU2128170C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
RU95120168A 1993-02-17 1994-02-17 Производные индолин-2-она и промежуточные продукты для их получения RU2128170C1 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP6729793 1993-02-17
JP67297/1993 1993-02-17
JP16726293 1993-05-31
JP167262/1993 1993-05-31
PCT/JP1994/000235 WO1994019322A1 (en) 1993-02-17 1994-02-17 Indolin-2-one derivative

Publications (2)

Publication Number Publication Date
RU95120168A RU95120168A (ru) 1997-09-27
RU2128170C1 true RU2128170C1 (ru) 1999-03-27

Family

ID=26408486

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95120168A RU2128170C1 (ru) 1993-02-17 1994-02-17 Производные индолин-2-она и промежуточные продукты для их получения

Country Status (19)

Country Link
US (5) US5952511A (enExample)
EP (1) EP0685463B1 (enExample)
JP (1) JP3419539B2 (enExample)
KR (1) KR100226310B1 (enExample)
CN (1) CN1046268C (enExample)
AT (1) ATE217864T1 (enExample)
AU (1) AU6044894A (enExample)
CA (1) CA2156287C (enExample)
CZ (1) CZ290504B6 (enExample)
DE (1) DE69430664T2 (enExample)
ES (1) ES2176236T3 (enExample)
FI (1) FI112652B (enExample)
HU (1) HUT74105A (enExample)
MY (1) MY128102A (enExample)
NO (1) NO305201B1 (enExample)
PL (1) PL176710B1 (enExample)
RU (1) RU2128170C1 (enExample)
TW (1) TW281669B (enExample)
WO (1) WO1994019322A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2379289C2 (ru) * 2004-10-27 2010-01-20 Киссеи Фармасьютикал Ко., Лтд. Соединение индолина и способ его получения

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040122000A1 (en) 1981-01-07 2004-06-24 Vertex Pharmaceuticals Incorporated. Inhibitors of aspartyl protease
US6878728B1 (en) 1999-06-11 2005-04-12 Vertex Pharmaceutical Incorporated Inhibitors of aspartyl protease
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
US5783701A (en) 1992-09-08 1998-07-21 Vertex Pharmaceuticals, Incorporated Sulfonamide inhibitors of aspartyl protease
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
DK0731091T3 (da) * 1993-11-26 2002-04-15 Tanabe Seiyaku Co 2-oxoindolin-derivater som cholecystokininreceptor-antagonister
DE69512220T2 (de) * 1994-03-07 2000-03-16 Vertex Pharmaceuticals Inc. Sulfonamidderivate als aspartylprotease-inhibitoren
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
US6004957A (en) * 1995-06-07 1999-12-21 Vertex Pharmaceuticals, Incorporated Sulfonamide inhibitors of aspartyl protease
AU2233097A (en) * 1996-03-11 1997-10-01 Chugai Seiyaku Kabushiki Kaisha Process for the preparation of optically active indole compounds
WO1998002419A1 (en) * 1996-07-12 1998-01-22 Chugai Seiyaku Kabushiki Kaisha Cancer cell proliferation inhibitors
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
DK1086076T3 (da) 1998-06-19 2005-03-29 Vertex Pharma Sulfonamidinhibitorer af aspartylprotease
DE69922997T2 (de) * 1998-12-04 2005-12-15 Neurosearch A/S Verwendung von isatinderivaten als ionenkanalaktivierende mittel
US6605623B1 (en) 1998-12-18 2003-08-12 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
ES2228451T3 (es) 1999-01-29 2005-04-16 Chugai Seiyaku Kabushiki Kaisha Promotores de condrogenesis y derivados de indolin-2-ona.
WO2000064872A1 (en) * 1999-04-23 2000-11-02 Vertex Pharmaceuticals Incorporated INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK)
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
ATE514674T1 (de) 1999-11-23 2011-07-15 Methylgene Inc Inhibitoren für histone-deacetylase
AU2001236058A1 (en) * 2000-03-10 2001-09-17 Chugai Seiyaku Kabushiki Kaisha Preparations for chondrogenesis
US7612065B2 (en) 2000-04-21 2009-11-03 Vertex Pharmaceuticals Incorporated Inhibitors of c-JUN N-terminal kinases (JNK)
AU2001268607A1 (en) 2000-06-21 2002-01-02 Bristol-Myers Squibb Company Piperidine amides as modulators of chemokine receptor activity
JP2004517803A (ja) * 2000-06-21 2004-06-17 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー ケモカイン受容体活性調節剤としてのｎ−ウレイドアルキル−ピペリジン
WO2004056769A2 (en) * 2002-12-20 2004-07-08 Ciba Specialty Chemicals Holding Inc. Synthesis of amines and intermediates for the synthesis thereof
CN1324009C (zh) * 2003-01-30 2007-07-04 普文英 化合物1－n－甲氧基－2－氧－吲哚－3－乙酰胺及其药物用途
WO2008027692A2 (en) * 2006-08-02 2008-03-06 Abu-Ageel Nayef M Led-based illumination system
US20090050905A1 (en) * 2007-08-20 2009-02-26 Abu-Ageel Nayef M Highly Efficient Light-Emitting Diode
US20100202129A1 (en) * 2009-01-21 2010-08-12 Abu-Ageel Nayef M Illumination system utilizing wavelength conversion materials and light recycling
US8987310B2 (en) 2009-10-30 2015-03-24 Merck Sharp & Dohme Corp. Heterocycle amide T-type calcium channel antagonists
CN102516153B (zh) * 2011-12-14 2014-03-12 南京工业大学 5-氟吲哚-2-酮-3-脲类化合物及其制备方法和应用
DK3071206T3 (da) 2013-11-22 2021-05-25 CL BioSciences LLC Gastrinantagonister (eg yf476, netazepid) til behandling og forebyggelse af osteoporose
KR102161674B1 (ko) * 2014-02-18 2020-10-05 주식회사 대웅제약 이사틴 유도체 및 이의 제조방법
CN113456631B (zh) * 2021-08-06 2022-06-21 徐州医科大学 一种靶向acsl1的小分子药物及其在治疗子宫内膜癌中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
JPS62234080A (ja) * 1985-12-20 1987-10-14 Kissei Pharmaceut Co Ltd インドリン−２−オン誘導体
JPS62228072A (ja) * 1985-12-20 1987-10-06 Kissei Pharmaceut Co Ltd ３−アミノインドリン−２−オン誘導体
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
JPS62270576A (ja) * 1986-05-19 1987-11-24 Kissei Pharmaceut Co Ltd イサチン誘導体
JPS62156771A (ja) * 1986-12-19 1987-07-11 Tokyo Shokai:Kk 処方箋処理装置
JPS63156771A (ja) * 1986-12-19 1988-06-29 Kissei Pharmaceut Co Ltd ３−アミノインドリン−２−オン誘導体
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
EP0442878A4 (en) * 1988-04-05 1991-10-23 Abbott Laboratories Derivatives of tryptophan as cck antagonists
DE69132805T2 (de) * 1990-08-31 2002-10-24 Warner-Lambert Co., Ann Arbor Pro-medikamente für cck-antagonisten
WO1992007830A2 (en) * 1990-10-29 1992-05-14 Pfizer Inc. Oxindole peptide antagonists
CA2055094A1 (en) * 1990-11-13 1992-05-14 Mark G. Bock Cholecystokinin antagonist
JPH05104510A (ja) * 1991-10-18 1993-04-27 Inax Corp 基板へのモルタル塗布方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JP, выложенная заявка 238069/88, 1988 Машковский М.Д. "Лекарственные средства", Москва, Медицина, 1972, ч.2, с.157 - 159, 350, 454, 471. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2379289C2 (ru) * 2004-10-27 2010-01-20 Киссеи Фармасьютикал Ко., Лтд. Соединение индолина и способ его получения

Also Published As

Publication number Publication date
CZ290504B6 (cs) 2002-08-14
US6207836B1 (en) 2001-03-27
FI953866A0 (fi) 1995-08-16
MY128102A (en) 2007-01-31
CZ209695A3 (en) 1995-12-13
EP0685463B1 (en) 2002-05-22
ATE217864T1 (de) 2002-06-15
JP3419539B2 (ja) 2003-06-23
FI953866A7 (fi) 1995-08-16
NO953235D0 (no) 1995-08-17
KR100226310B1 (ko) 1999-10-15
AU6044894A (en) 1994-09-14
EP0685463A4 (enExample) 1996-01-03
DE69430664D1 (de) 2002-06-27
US6031111A (en) 2000-02-29
JPH0748349A (ja) 1995-02-21
CA2156287C (en) 2005-12-27
ES2176236T3 (es) 2002-12-01
US6127544A (en) 2000-10-03
HU9502415D0 (en) 1996-05-28
FI112652B (fi) 2003-12-31
PL176710B1 (pl) 1999-07-30
CN1117727A (zh) 1996-02-28
WO1994019322A1 (en) 1994-09-01
DE69430664T2 (de) 2003-01-30
US5952511A (en) 1999-09-14
PL310168A1 (en) 1995-11-27
KR960701011A (ko) 1996-02-24
CA2156287A1 (en) 1994-09-01
HUT74105A (en) 1996-11-28
TW281669B (enExample) 1996-07-21
US6114536A (en) 2000-09-05
NO305201B1 (no) 1999-04-19
NO953235L (no) 1995-10-09
EP0685463A1 (en) 1995-12-06
CN1046268C (zh) 1999-11-10

Similar Documents

Publication Publication Date Title
RU2128170C1 (ru) Производные индолин-2-она и промежуточные продукты для их получения
JP3263081B2 (ja) バソプレシンおよび／またはオシトシン作動薬および／または拮抗薬としての窒素基によって３位において置換されている１，３−ジヒドロインドール−２−オン誘導体
AU675447B2 (en) Carboxamidomethyl piperidine and analogues
ES2224159T3 (es) Esteres y amidas de 1,4-piperidina disustituidos con actividad antagonista de 5-ht4.
SK42693A3 (en) Indoline derivatives with amidic group
AU2005224129B2 (en) Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
RU2591190C2 (ru) Новые 4-амино-n-гидроксибензамиды в качестве ингибиторов hdac для лечения рака
FR2676054A1 (fr) Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
HUT56543A (en) Process for producing aromatic amines and pharmaceutical compositions comprising such compounds
HUP0101511A2 (hu) 1-[(1-Szubsztituált-4-piperidinil)-metil]-4-piperidin-származékok, eljárás a vegyületek előállítására, a vegyületeket tartalmazó gyógyászati készítmények és intermedierjeik
SK404291A3 (en) INDOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION COMPRISING THEMì (54) AND THEIR USE
CZ20014496A3 (cs) Indolové deriváty a jejich pouľití pro léčení osteoporózy
HU226395B1 (en) Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists, pharmaceutical compositions containing them and process for producing them
KR101176675B1 (ko) 테트라히드로이소퀴놀린 술폰아미드 유도체, 이의 제조, 및치료에서의 이의 용도
JPH01186866A (ja) 分割化アミノピロリジン神経防護剤
JPH0525140A (ja) ベンズイミダゾール誘導体
FR2676227A1 (fr) Nouveaux intermediaires pour la synthese de composes dialkylenepiperidino.
JPH05385B2 (enExample)
HK1123789B (en) Azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
HK1185874B (en) Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20070218